267,533 Shares in Henry Schein, Inc. (NASDAQ:HSIC) Acquired by Artisan Partners Limited Partnership

Artisan Partners Limited Partnership purchased a new stake in shares of Henry Schein, Inc. (NASDAQ:HSICFree Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 267,533 shares of the company’s stock, valued at approximately $19,864,000. Artisan Partners Limited Partnership owned 0.20% of Henry Schein at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Xponance Inc. raised its position in Henry Schein by 2.1% during the third quarter. Xponance Inc. now owns 21,839 shares of the company’s stock valued at $1,622,000 after buying an additional 443 shares during the period. Barclays PLC raised its position in Henry Schein by 130.2% during the second quarter. Barclays PLC now owns 250,395 shares of the company’s stock valued at $20,305,000 after buying an additional 141,618 shares during the period. Kentucky Retirement Systems Insurance Trust Fund acquired a new position in Henry Schein during the third quarter valued at $348,000. Bessemer Group Inc. raised its position in Henry Schein by 26.0% during the second quarter. Bessemer Group Inc. now owns 6,437 shares of the company’s stock valued at $522,000 after buying an additional 1,328 shares during the period. Finally, Van ECK Associates Corp raised its position in Henry Schein by 6.4% during the second quarter. Van ECK Associates Corp now owns 16,316 shares of the company’s stock valued at $1,323,000 after buying an additional 978 shares during the period. 93.31% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, CEO Stanley M. Bergman sold 13,962 shares of the firm’s stock in a transaction that occurred on Tuesday, December 26th. The stock was sold at an average price of $75.14, for a total value of $1,049,104.68. Following the sale, the chief executive officer now owns 168,633 shares of the company’s stock, valued at approximately $12,671,083.62. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other Henry Schein news, CEO Bradford C. Connett sold 11,238 shares of the firm’s stock in a transaction that occurred on Thursday, December 21st. The stock was sold at an average price of $74.02, for a total value of $831,836.76. Following the sale, the chief executive officer now owns 57,831 shares of the company’s stock, valued at approximately $4,280,650.62. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Stanley M. Bergman sold 13,962 shares of the firm’s stock in a transaction that occurred on Tuesday, December 26th. The shares were sold at an average price of $75.14, for a total value of $1,049,104.68. Following the completion of the sale, the chief executive officer now directly owns 168,633 shares in the company, valued at approximately $12,671,083.62. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the company. UBS Group cut their price target on Henry Schein from $82.00 to $75.00 and set a “neutral” rating for the company in a research note on Tuesday, November 14th. Piper Sandler cut their price target on Henry Schein from $94.00 to $84.00 and set an “overweight” rating for the company in a research note on Thursday, October 26th. TheStreet downgraded Henry Schein from a “b-” rating to a “c+” rating in a research note on Thursday, November 2nd. Barrington Research cut their price target on Henry Schein from $90.00 to $82.00 and set an “outperform” rating for the company in a research note on Tuesday, November 14th. Finally, JPMorgan Chase & Co. raised Henry Schein from a “neutral” rating to an “overweight” rating and raised their price target for the stock from $71.00 to $82.00 in a research note on Tuesday, December 12th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and five have given a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $79.25.

Get Our Latest Stock Report on HSIC

Henry Schein Stock Down 1.6 %

Shares of HSIC stock opened at $73.72 on Friday. The stock’s 50 day simple moving average is $74.14 and its 200 day simple moving average is $73.00. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.09 and a current ratio of 1.97. Henry Schein, Inc. has a twelve month low of $60.01 and a twelve month high of $89.60. The company has a market capitalization of $9.58 billion, a price-to-earnings ratio of 21.94, a PEG ratio of 2.42 and a beta of 0.87.

Henry Schein (NASDAQ:HSICGet Free Report) last issued its quarterly earnings data on Monday, November 13th. The company reported $1.32 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.32. Henry Schein had a return on equity of 16.08% and a net margin of 3.51%. The business had revenue of $3.16 billion for the quarter, compared to the consensus estimate of $3.21 billion. During the same period last year, the business earned $1.15 EPS. The firm’s revenue was up 3.1% compared to the same quarter last year. As a group, research analysts predict that Henry Schein, Inc. will post 4.56 EPS for the current year.

About Henry Schein

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

See Also

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.